Aduro BioTech Obtains $119,000,000 New Funding

  • Feed Type
  • Date
  • Company Name
    Aduro BioTech
  • Mailing Address
    626 Bancroft Way Berkeley, CA 94710 USA
  • Company Description
    Aduro BioTech (NASDAQ: ADRO) is an immunotherapy company with a platform technology for therapeutic and prophylactic vaccines for cancer and infectious diseases.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms

Trending on Xconomy